1
|
Roy P, Shrestha D, Akhtar MS, Lee YR. Rh-Catalyzed Annulation of Enaminones with Maleimides for Functionalized Aza-spiro α-Tetralones and Benzo[ e]isoindoles via C-H Activation/C═C Bond Cleavage. Org Lett 2024; 26:142-147. [PMID: 38109110 DOI: 10.1021/acs.orglett.3c03758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2023]
Abstract
An unprecedented strategy for Rh-catalyzed C-H activation/C═C bond cleavage of enaminones is described for the construction of biologically interesting aza-spiro α-tetralones and benzo[e]isoindoles. This protocol provides diversely functionalized aza-spiro α-tetralones and benzo[e]isoindoles in good yields via a [4 + 2] annulation of the exomaleimides and maleimides. This strategy displays a good substrate scope, outstanding functional group tolerance, and excellent regioselectivity.
Collapse
Affiliation(s)
- Prasanta Roy
- School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea
| | - Divya Shrestha
- School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea
| | - Muhammad Saeed Akhtar
- School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea
| | - Yong Rok Lee
- School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea
| |
Collapse
|
2
|
Szaryńska M, Olejniczak-Kęder A, Podpłońska K, Prahl A, Iłowska E. Bradykinin and Neurotensin Analogues as Potential Compounds in Colon Cancer Therapy. Int J Mol Sci 2023; 24:ijms24119644. [PMID: 37298595 DOI: 10.3390/ijms24119644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2023] [Revised: 05/29/2023] [Accepted: 05/30/2023] [Indexed: 06/12/2023] Open
Abstract
Colorectal cancer (CRC) is one of the most lethal malignancies worldwide, so the attempts to find novel therapeutic approaches are necessary. The aim of our study was to analyze how chemical modifications influence physical, chemical, and biological properties of the two peptides, namely, bradykinin (BK) and neurotensin (NT). For this purpose, we used fourteen modified peptides, and their anti-cancers features were analyzed on the HCT116 CRC cell line. Our results confirmed that the spherical mode of a CRC cell line culture better reflects the natural tumour microenvironment. We observed that the size of the colonospheres was markedly reduced following treatment with some BK and NT analogues. The proportion of CD133+ cancer stem cells (CSCs) in colonospheres decreased following incubation with the aforementioned peptides. In our research, we found two groups of these peptides. The first group influenced all the analyzed cellular features, while the second seemed to include the most promising peptides that lowered the count of CD133+ CSCs with parallel substantial reduction in CRC cells viability. These analogues need further analysis to uncover their overall anti-cancer potential.
Collapse
Affiliation(s)
- Magdalena Szaryńska
- Department of Histology, Faculty of Medicine, Medical University of Gdansk, 80-210 Gdansk, Poland
| | - Agata Olejniczak-Kęder
- Department of Histology, Faculty of Medicine, Medical University of Gdansk, 80-210 Gdansk, Poland
| | - Kamila Podpłońska
- Department of Histology, Faculty of Medicine, Medical University of Gdansk, 80-210 Gdansk, Poland
| | - Adam Prahl
- Department of Organic Chemistry, Faculty of Chemistry, University of Gdansk, 80-308 Gdansk, Poland
| | - Emilia Iłowska
- Department of Organic Chemistry, Faculty of Chemistry, University of Gdansk, 80-308 Gdansk, Poland
| |
Collapse
|
3
|
Spectroscopic characterization and in vitro studies of biological activity of bradykinin derivatives. Sci Rep 2022; 12:19015. [PMID: 36348016 PMCID: PMC9643506 DOI: 10.1038/s41598-022-23448-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2022] [Accepted: 10/31/2022] [Indexed: 11/10/2022] Open
Abstract
Eleven multiple analogs of bradykinin-a peptide that is a natural ligand of B1 and B2 receptors but does not bind or activate the B1 receptor unless Arg9 is removed from the sequence by the action of carboxypeptidase N-were synthesized. Their biological activity was examined on T-REx cell lines expressing B1 or B2 receptors using the intracellular IP1 assay. The mRNA expression of B1R and B2R in the lysate of tumor cell lines, e.g., U87-MG (human astrocytoma), SHP-77 (human small cell lung cancer), and H4 (human brain glioma), was determined. For five B1R antagonists, adsorption at the liquid/solid interface (Au nanoparticles (AuNPs) served as the solid surface) was discussed in terms of the vibrations of molecular fragments (structural factors) responsible for the biological properties of these analogs.
Collapse
|
4
|
Jiao MJ, Hu Q, Hu XQ, Xu PF. Visible-Light-Promoted Multistep Tandem Reaction of Vinyl Azides toward the Formation of 1-Tetralones. J Org Chem 2021; 86:17156-17163. [PMID: 34794309 DOI: 10.1021/acs.joc.1c02261] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
A visible-light-driven multistep tandem reaction between vinyl azides and alkyl bromides has been developed leading to the formation of tetralone skeletons under mild conditions, which can be easily scaled up to the gram scale. Various 1-tetralone derivatives are synthesized and transformed into desired products in good to high yields.
Collapse
Affiliation(s)
- Meng-Jie Jiao
- State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, P. R. China
| | - Qiang Hu
- State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, P. R. China
| | - Xiu-Qin Hu
- State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, P. R. China
| | - Peng-Fei Xu
- State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, P. R. China.,State Key Laboratory of Veterinary Etiological Biology, College of Veterinary Medicine, Lanzhou University, Lanzhou 730000, P. R. China
| |
Collapse
|
5
|
Schmid M, Grossmann AS, Mayer P, Müller T, Magauer T. Ring-Expansion Approaches for the Total Synthesis of Salimabromide. Tetrahedron 2019; 75:3195-3215. [PMID: 31160829 PMCID: PMC6544523 DOI: 10.1016/j.tet.2019.03.010] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
We describe the evolution of a synthetic strategy for the construction of the marine polyketide salimabromide. Combining a bicyclo[3.1.0]hexan-2-one ring-expansion to build up a functionalized naphthalene and an unprecedented rearrangement/cyclization cascade, enabled synthesis of a dearomatized tricyclic subunit of the target compound. Alternatively, an intramolecular ketiminium [2+2]-cycloaddition and subsequent Baeyer-Villiger ring-expansion gave access to the sterically encumbered architecture of salimabromide. Sequential oxidation of the carbon framework finally enabled the total synthesis of this unusual natural product.
Collapse
Affiliation(s)
- Matthias Schmid
- Department of Chemistry and Pharmacy, Ludwig-Maximilians-University Munich, Butenandtstraße 5-13, Munich 81377, Germany
- Institute of Organic Chemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| | - Adriana S Grossmann
- Department of Chemistry and Pharmacy, Ludwig-Maximilians-University Munich, Butenandtstraße 5-13, Munich 81377, Germany
| | - Peter Mayer
- Department of Chemistry and Pharmacy, Ludwig-Maximilians-University Munich, Butenandtstraße 5-13, Munich 81377, Germany
| | - Thomas Müller
- Institute of Organic Chemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| | - Thomas Magauer
- Institute of Organic Chemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
| |
Collapse
|
6
|
Yu J, Zhao H, Liang S, Bao X, Zhu C. A facile and regioselective synthesis of 1-tetralones via silver-catalyzed ring expansion. Org Biomol Chem 2015; 13:7924-7. [DOI: 10.1039/c5ob01222h] [Citation(s) in RCA: 54] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
A regioselective synthesis of 1-tetralones via silver-catalyzed ring expansion is described.
Collapse
Affiliation(s)
- Jiajia Yu
- Key Laboratory of Organic Synthesis of Jiangsu Province
- College of Chemistry
- Chemical Engineering and Materials Science
- Soochow University
- Suzhou
| | - Huijun Zhao
- Key Laboratory of Organic Synthesis of Jiangsu Province
- College of Chemistry
- Chemical Engineering and Materials Science
- Soochow University
- Suzhou
| | - Shuguang Liang
- Key Laboratory of Organic Synthesis of Jiangsu Province
- College of Chemistry
- Chemical Engineering and Materials Science
- Soochow University
- Suzhou
| | - Xiaoguang Bao
- College of Chemistry
- Chemical Engineering and Materials Science
- Soochow University
- Suzhou
- People's Republic of China
| | - Chen Zhu
- Key Laboratory of Organic Synthesis of Jiangsu Province
- College of Chemistry
- Chemical Engineering and Materials Science
- Soochow University
- Suzhou
| |
Collapse
|
7
|
Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency. Bioorg Med Chem Lett 2012; 22:1061-7. [DOI: 10.1016/j.bmcl.2011.11.112] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2011] [Revised: 11/23/2011] [Accepted: 11/28/2011] [Indexed: 11/23/2022]
|
8
|
3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation. Bioorg Med Chem Lett 2011; 21:3384-9. [DOI: 10.1016/j.bmcl.2011.03.115] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2011] [Revised: 03/28/2011] [Accepted: 03/31/2011] [Indexed: 11/20/2022]
|
9
|
Huang H, Player MR. Bradykinin B1 receptor antagonists as potential therapeutic agents for pain. J Med Chem 2010; 53:5383-99. [PMID: 20369879 DOI: 10.1021/jm1000776] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Affiliation(s)
- Hui Huang
- Johnson & Johnson Pharmaceutical Research and Development, Spring House, Pennsylvania 19477-0776, USA
| | | |
Collapse
|
10
|
Liu Q, Qian W, Li A, Biswas K, Chen JJ, Fotsch C, Han N, Yuan C, Arik L, Biddlecome G, Johnson E, Kumar G, Lester-Zeiner D, Ng GY, Hungate RW, Askew BC. Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists. Bioorg Med Chem Lett 2010; 20:4593-7. [PMID: 20573508 DOI: 10.1016/j.bmcl.2010.06.010] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2010] [Revised: 05/28/2010] [Accepted: 06/02/2010] [Indexed: 11/17/2022]
Abstract
The bradykinin B1 receptor has been shown to mediate pain response and is rapidly induced upon injury. Blocking this receptor may provide a promising treatment for inflammation and pain. We previously reported tetralin benzyl amines as potent B1 antagonists. Here we describe the synthesis and SAR of B1 receptor antagonists with homobenzylic amines. The SAR of different linkers led to the discovery of tetralin allylic amines as potent and selective B1 receptor antagonists (hB1 IC(50)=1.3 nM for compound 16). Some of these compounds showed modest oral bioavailability in rats.
Collapse
Affiliation(s)
- Qingyian Liu
- Chemistry Research and Discovery, Amgen Inc., Thousand Oaks, CA 91320, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
TAO X, DAI C, CAO X, CAI L, PIKE VW. Palladium-catalyzed Substitution of Ketone or Aldehyde Bearing Aryl Triflates by Amines or Amides. CHINESE J CHEM 2009. [DOI: 10.1002/cjoc.200990066] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
12
|
Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists. Bioorg Med Chem Lett 2009; 19:119-22. [DOI: 10.1016/j.bmcl.2008.11.005] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2008] [Revised: 10/28/2008] [Accepted: 11/03/2008] [Indexed: 11/21/2022]
|
13
|
Aryl sulfones as novel Bradykinin B1 receptor antagonists for treatment of chronic pain. Bioorg Med Chem Lett 2008; 18:4764-9. [DOI: 10.1016/j.bmcl.2008.07.108] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2008] [Revised: 07/23/2008] [Accepted: 07/28/2008] [Indexed: 11/22/2022]
|
14
|
Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists. Bioorg Med Chem Lett 2008; 18:4477-81. [DOI: 10.1016/j.bmcl.2008.07.055] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2008] [Revised: 07/09/2008] [Accepted: 07/14/2008] [Indexed: 11/19/2022]
|
15
|
Chen JJ, Biswas K. Small molecule bradykinin B1 receptor antagonists as potential therapeutic agents for pain. PROGRESS IN MEDICINAL CHEMISTRY 2008; 46:173-204. [PMID: 18381126 DOI: 10.1016/s0079-6468(07)00004-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Affiliation(s)
- Jian Jeffrey Chen
- Chemistry Research and Discovery, Amgen Inc., MS 29-1-B, One Amgen Center Drive, Thousand Oaks, CA 91320, USA
| | | |
Collapse
|
16
|
Abstract
The bradykinin B1 receptor is an inducible G-protein-coupled receptor. It is induced or upregulated at the site of inflammation or injury. A large body of preclinical data supports the development of B1 antagonists as novel therapeutics for the treatment of pain and inflammation. The necessary in vitro and in vivo drug discovery tools are currently available to evaluate novel B1 antagonists. Two major classes of small-molecule B1 antagonists, arylsulfonamide-based and biphenyl-based B1 antagonists, have been disclosed in the last few years.
Collapse
Affiliation(s)
- Jian Jeffrey Chen
- Amgen Inc., Chemistry Research and Development, One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
| | | |
Collapse
|